Traditional Chinese medicine composition with efficacy of assisting in treatment of pulmonary infection

Abstract

The invention applies to anti-infection adjunctive treatment of the lung of a patient suffering from AECOPD (acute exacerbation chronic obstructive pulmonary disease) complicated by pulmonary hypertension and discloses traditional Chinese medicine composition with efficacy of assisting in treatment of pulmonary infection. The traditional Chinese medicine composition comprises raw materials in parts by weight as follows: 600-1,200 parts of Chinese angelica, 600-1,200 parts of dried rehmannia, 900-1,500 parts of peach kernels, 600-1,200 parts of safflower, 400-800 parts of bitter oranges, 400-800 parts of red paeony roots, 100-500 parts of radix bupleuri, 100-500 parts of liquorice, 200-600 parts of platycodon roots, 200-600 parts of rhizoma chuanxiong and 700-1,200 parts of achyranthes bidentata. The Chinese angelica, the dried rehmannia, the peach kernels, the safflower, the red paeony roots and the rhizoma chuanxiong can activate the blood, remove blood stasis, nourish blood and prevent vital qi damage caused by pure removal of blood stasis; immature bitter orange, the radix bupleuri and the liquorice promote circulation of liver energy, and blood circulation is promoted after the liver energy circulation is promoted; the platycodon roots are added, the traditional Chinese medicine composition is guided to move up to the blood house of the chest; the achyranthes bidentata promotes downward movement of static blood, and accordingly, blood circulation is promoted. The traditional Chinese medicine composition can well assist antibiotic in treatment of pulmonary infection based on AECOPD complicated by pulmonary hypertension.

Description

technical field [0001] The invention belongs to the field of application of traditional Chinese medicine in critical care medicine, especially the adjuvant pulmonary anti-infection treatment for patients whose underlying disease is acute exacerbation of chronic obstructive pulmonary disease (hereinafter referred to as AECOPD) combined with pulmonary hypertension. Background technique [0002] Pulmonary hypertension is an important factor leading to the deterioration of the clinical process, and pulmonary infection on the basis of AECOPD pulmonary hypertension is often an important cause of death in patients. For the treatment of this kind of pulmonary infection, because most patients are accompanied by other systemic complications, the anti-infection effect of simply using antibiotics often cannot reach the satisfactory therapeutic effect of clinicians. Contents of the invention [0003] The technical problem solved by the invention [0004] Through the application of tra...

AI Technical Summary

Problems solved by technology

For the treatment of this kind of pulmonary infection, because most patients are accompanied by other systemic complications, the anti-infection effect of antibiotics alone is often not satisfactory for clinicians.

Images